Bodhi Tree Biotechnology INC
Quarterly Earnings (10-Q)
OQB
Bodhi Tree Biotechnology Inc. reported increased revenues for the second quarter of fiscal year 2026, though the company continues to operate at a net loss.
OQB
Bodhi Tree Biotechnology Inc. reported zero revenue for the quarter ended December 31, 2025, alongside material weaknesses in internal controls.
Capital raise
Worse than expected
Annual Reports (10-K)
OQB
Bodhi Tree Biotechnology Inc., an early-stage plant-based consulting firm, reported a significant increase in net loss and a decrease in revenue for the fiscal year ended September 30, 2025, alongside challenges in internal controls and market liquidity.
Delay expected
Capital raise
Worse than expected